Amanda Quijano Selected Research

dolichyl-diphosphooligosaccharide - protein glycotransferase (oligosaccharyltransferase)

1/2019	Oligosaccharyltransferase Inhibition Reduces Receptor Tyrosine Kinase Activation and Enhances Glioma Radiosensitivity.
1/2018	Oligosaccharyltransferase Inhibition Overcomes Therapeutic Resistance to EGFR Tyrosine Kinase Inhibitors.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Amanda Quijano Research Topics

Disease

2	Neoplasms (Cancer) 01/2019 - 01/2018
1	Glioma (Gliomas) 01/2019
1	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 01/2018
1	Lung Neoplasms (Lung Cancer) 01/2018

Drug/Important Bio-Agent (IBA)

2	Proteins (Proteins, Gene)FDA Link 01/2019 - 01/2018
2	dolichyl-diphosphooligosaccharide - protein glycotransferase (oligosaccharyltransferase)IBA 01/2019 - 01/2018
1	Receptor Protein-Tyrosine Kinases (Tyrosine Kinase Receptors)IBA 01/2019
1	Phosphotransferases (Kinase)IBA 01/2018
1	Glycoproteins (Glycoprotein)IBA 01/2018
1	Tyrosine Kinase InhibitorsIBA 01/2018

Therapy/Procedure

2	Therapeutics 01/2019 - 01/2018
1	Drug Therapy (Chemotherapy) 01/2019
1	Radiotherapy 01/2019